Kala Bio Operating Expenses Growth & History (KALA)
Kala Bio's operating expenses was $39.2M for fiscal 2025.
View full Kala Bio company overviewKala Bio annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $39.2M | −$1.8M | −4.45% |
| 2024 | 2024-12-31 | $41.0M | $1.3M | +3.33% |
| 2023 | 2023-12-31 | $39.7M | −$45.9M | −53.66% |
| 2022 | 2022-12-31 | $85.6M | −$55.9M | −39.50% |
| 2021 | 2021-12-31 | $141.5M | $38.9M | +37.91% |
| 2020 | 2020-12-31 | $102.6M | $8.3M | +8.80% |
| 2019 | 2019-12-31 | $94.3M | $29.6M | +45.70% |
| 2018 | 2018-12-31 | $64.7M | $24.8M | +62.31% |
| 2017 | 2017-12-31 | $39.9M | $7.2M | +22.06% |
| 2016 | 2016-12-31 | $32.7M | $16.7M | +104.30% |
| 2015 | 2015-12-31 | $16.0M | — | — |
Kala Bio quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.7M | −$9.3M | −84.39% |
| Q1 2026 | 2026-03-31 | $1.8M | −$8.9M | −83.11% |
| Q4 2025 | 2025-12-31 | $10.2M | $766,000 | +8.10% |
| Q3 2025 | 2025-09-30 | $7.2M | −$2.7M | −27.52% |
| Q2 2025 | 2025-06-30 | $11.0M | $1.4M | +14.82% |
| Q1 2025 | 2025-03-31 | $10.7M | −$1.3M | −10.58% |
| Q4 2024 | 2024-12-31 | $9.5M | −$160,000 | −1.66% |
| Q3 2024 | 2024-09-30 | $10.0M | $1.2M | +13.99% |
| Q2 2024 | 2024-06-30 | $9.6M | $6,000 | +0.06% |
| Q1 2024 | 2024-03-31 | $11.9M | $248,000 | +2.12% |
| Q4 2023 | 2023-12-31 | $9.6M | −$632,000 | −6.17% |
| Q3 2023 | 2023-09-30 | $8.8M | −$6.2M | −41.54% |
| Q2 2023 | 2023-06-30 | $9.6M | −$18.5M | −65.81% |
| Q1 2023 | 2023-03-31 | $11.7M | −$20.6M | −63.81% |
| Q4 2022 | 2022-12-31 | $10.3M | −$38.4M | −78.94% |
| Q3 2022 | 2022-09-30 | $15.0M | −$14.1M | −48.56% |
| Q2 2022 | 2022-06-30 | $28.1M | −$4.0M | −12.54% |
| Q1 2022 | 2022-03-31 | $32.3M | $706,000 | +2.24% |
| Q4 2021 | 2021-12-31 | $48.7M | $17.4M | +55.89% |
| Q3 2021 | 2021-09-30 | $29.1M | $1.1M | +3.83% |
| Q2 2021 | 2021-06-30 | $32.1M | $10.0M | +45.15% |
| Q1 2021 | 2021-03-31 | $31.6M | $10.4M | +48.99% |
| Q4 2020 | 2020-12-31 | $31.2M | $9.8M | +46.05% |
| Q3 2020 | 2020-09-30 | $28.1M | $5.0M | +21.91% |
| Q2 2020 | 2020-06-30 | $22.1M | −$2.4M | −9.62% |
| Q1 2020 | 2020-03-31 | $21.2M | −$4.2M | −16.67% |
| Q4 2019 | 2019-12-31 | $21.4M | −$2.2M | −9.29% |
| Q3 2019 | 2019-09-30 | $23.0M | $7.5M | +48.54% |
| Q2 2019 | 2019-06-30 | $24.5M | $9.9M | +68.52% |
| Q1 2019 | 2019-03-31 | $25.4M | $14.3M | +128.35% |
| Q4 2018 | 2018-12-31 | $23.6M | $12.4M | +111.55% |
| Q3 2018 | 2018-09-30 | $15.5M | $6.0M | +62.53% |
| Q2 2018 | 2018-06-30 | $14.5M | $4.9M | +50.77% |
| Q1 2018 | 2018-03-31 | $11.1M | $1.6M | +16.38% |
| Q4 2017 | 2017-12-31 | $11.1M | $2.9M | +35.92% |
| Q3 2017 | 2017-09-30 | $9.5M | −$213,000 | −2.19% |
| Q2 2017 | 2017-06-30 | $9.6M | −$20,000 | −0.21% |
| Q1 2017 | 2017-03-31 | $9.6M | $4.5M | +88.55% |
| Q4 2016 | 2016-12-31 | $8.2M | — | — |
| Q3 2016 | 2016-09-30 | $9.7M | — | — |
| Q2 2016 | 2016-06-30 | $9.7M | — | — |
| Q1 2016 | 2016-03-31 | $5.1M | — | — |
Kala Bio operating expenses trends
Over the last five fiscal years, Kala Bio's operating expenses decreased from $102.6M to $39.2M, a change of −$63.4M. The latest reported quarter, Q2 2026, shows $1.7M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kala Bio source filings ↗